You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Details for Patent: 8,637,079


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,637,079 protect, and when does it expire?

Patent 8,637,079 protects OSENI and is included in one NDA.

This patent has forty-three patent family members in thirty-eight countries.

Summary for Patent: 8,637,079
Title:Solid preparation comprising alogliptin and pioglitazone
Abstract: A solid preparation containing compound (I), wherein the definition of compound (I) is as defined in the description, and pioglitazone, which is useful as a therapeutic drug for diabetes and the like and superior in the dissolution property, chemical stability and dissolution stability, is provided. A solid preparation containing the following first and second parts: (1) the first part containing compound (I) or a salt thereof and, as the first excipient, sugar or sugar alcohol; and (2) the second part containing pioglitazone or a salt thereof and, as the second excipient, sugar or sugar alcohol.
Inventor(s): Nakamura; Kenji (Osaka, JP), Kiyoshima; Kenichiro (Osaka, JP), Nomura; Junya (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:12/449,255
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,637,079

Introduction

United States Patent 8,637,079, hereafter referred to as US Patent 8,637,079, is a patent that has been granted for a specific invention. To understand its significance and the protection it offers, it is crucial to delve into the details of its scope, claims, and the broader patent landscape.

Patent Overview

US Patent 8,637,079 was granted on January 28, 2014. Here are some key points about the patent:

  • Inventors and Assignees: The patent lists the inventors and the assignees, which are crucial for understanding the ownership and rights associated with the patent.
  • Expiration Date: The estimated expiration date of the patent is June 4, 2029, assuming no extensions or adjustments[1].

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific aspects of the invention that are protected.

Claims Structure

  • Independent and Dependent Claims: A patent typically includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The strategic management of these claims is vital for maximizing the patent’s value and breadth[2].
  • Claim Management: Effective claim management involves ensuring that the patent utilizes its full entitlement of claims. For example, if claims are canceled during the prosecution phase, adding new dependent claims can maintain the full quota of claims, enhancing the patent’s defensive capabilities and value[2].

Claims Analysis

To analyze the claims of US Patent 8,637,079, one must review each claim carefully.

Independent Claims

Independent claims are the cornerstone of the patent, defining the core aspects of the invention. These claims should be broad enough to cover the essential features of the invention but not so broad that they become invalid due to prior art.

Dependent Claims

Dependent claims build upon the independent claims, providing additional specificity and narrowing down the scope. These claims can help protect various facets of the invention and ensure comprehensive coverage.

Patent Landscape

Understanding the patent landscape involves analyzing how US Patent 8,637,079 fits into the broader context of related patents and technologies.

Patent Analytics

Using patent analytics tools, such as those described by Schwegman, can help categorize patents by claims and scope concepts. This approach allows for a more efficient analysis of large numbers of patent claims and helps identify gaps or opportunities in the current coverage[3].

Competitor Patents

Analyzing competitor patents in the same field can reveal potential overlaps or conflicts. For instance, if a competitor's patent has claims that are similar or overlapping, it may be necessary to assess the validity of those claims or negotiate licensing agreements.

Strategic Implications

The strategic management of claims in US Patent 8,637,079 can have significant implications.

Maximizing Value

By ensuring that the patent utilizes its full complement of claims, the inventor can secure a more robust and nuanced protection. This enhances the patent’s defensive capabilities and its value in potential licensing discussions or infringement disputes[2].

Licensing and Infringement

Each claim in the patent can be viewed as a unique tool for protecting different facets of the invention. This comprehensive protection can be a strong bargaining chip in licensing negotiations and a formidable defense against infringement claims.

Case Studies and Precedents

Understanding how other patents have been treated by the USPTO can provide valuable insights.

Rambus vs. NVIDIA

For example, the case of Rambus patents against NVIDIA highlights the importance of claim validity. The USPTO rejected all 17 claims in three Rambus patents, demonstrating that even seemingly strong patents can face challenges if their claims are not well-founded[5].

Practical Applications

The practical application of US Patent 8,637,079 involves integrating it into the company’s overall intellectual property strategy.

Claim Coverage Matrix

Using a Claim Coverage Matrix, as suggested by Schwegman, can help identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. This tool can be particularly useful for companies with a large portfolio of patents[3].

Interactive Claim Charts

Interactive claim charts generated by software like ClaimScape® can facilitate quick and accurate reviews of patent coverage with technical experts. These charts help determine if there are gaps in the current coverage and highlight future design opportunities[3].

Key Takeaways

  • Comprehensive Claim Management: Ensuring that the patent utilizes its full entitlement of claims is crucial for maximizing its value and breadth.
  • Patent Analytics: Using tools like Claim Coverage Matrix and interactive claim charts can help in analyzing and managing the patent landscape efficiently.
  • Strategic Implications: Effective claim management enhances the patent’s defensive capabilities and its value in licensing discussions and infringement disputes.
  • Case Studies: Understanding how other patents have been treated by the USPTO can provide valuable insights into the validity and strength of claims.

FAQs

  1. What is the significance of independent and dependent claims in a patent? Independent claims define the core aspects of the invention, while dependent claims provide additional specificity and narrow down the scope.

  2. How can patent analytics tools help in managing a patent portfolio? Patent analytics tools help categorize patents by claims and scope concepts, making it easier to identify gaps or opportunities in the current coverage.

  3. Why is it important to ensure that a patent utilizes its full entitlement of claims? Ensuring that a patent utilizes its full entitlement of claims maximizes its value and breadth, enhancing its defensive capabilities and value in licensing discussions or infringement disputes.

  4. What is the role of a Claim Coverage Matrix in patent management? A Claim Coverage Matrix shows which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist, helping to filter, search, and analyze large numbers of patent claims.

  5. How can interactive claim charts be useful in patent reviews? Interactive claim charts generated by software like ClaimScape® facilitate quick and accurate reviews of patent coverage with technical experts, helping to determine gaps in current coverage and highlight future design opportunities.

Sources

  1. DrugBank Online - Alogliptin: Uses, Interactions, Mechanism of Action
  2. Harrity LLP - Maximizing Patent Value: A Strategic Approach to Claim Management
  3. Schwegman, Lundberg & Woessner, P.A. - Patent Analytics
  4. DrugPatentWatch - Approved Drug Products with Therapeutic Equivalence Evaluations
  5. NVIDIA News - U.S. Patent Office Rejects All 17 Claims in Three Rambus Patents Asserted Against NVIDIA in International Trade Commission Action

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,637,079

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-004 Jan 25, 2013 DISCN Yes No 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-005 Jan 25, 2013 RX Yes No 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-006 Jan 25, 2013 DISCN Yes No 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-001 Jan 25, 2013 RX Yes No 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-002 Jan 25, 2013 RX Yes No 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
Takeda Pharms Usa OSENI alogliptin benzoate; pioglitazone hydrochloride TABLET;ORAL 022426-003 Jan 25, 2013 RX Yes Yes 8,637,079 ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 6 of 6 entries

Foreign Priority and PCT Information for Patent: 8,637,079

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2007-023594Feb 1, 2007
PCT Information
PCT FiledJanuary 30, 2008PCT Application Number:PCT/JP2008/051900
PCT Publication Date:August 07, 2008PCT Publication Number: WO2008/093882

International Family Members for US Patent 8,637,079

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 065097 ⤷  Try for Free
Australia 2008211981 ⤷  Try for Free
Austria E488227 ⤷  Try for Free
Brazil PI0807453 ⤷  Try for Free
Canada 2677201 ⤷  Try for Free
Chile 2008000279 ⤷  Try for Free
China 101646420 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.